A S X A N N O U N C E M E N T Melbourne, Australia, 6 October 2026 ASX: CUV | Nasdaq: CUVL | Börse Frankfurt: UR9 ASX Announcement PAGE 1 OF 2 Section 708A Cleansing Statement This notice is given by CLINUVEL PHARMACEUTICALS LIMITED (“Company”) under Section 708A(6) of the...
Section 708A Cleansing Statement
Filed with ASX ·
Watch Clinuvel Pharmaceuticals' latest callClinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call · Replay · Aug 27Read the transcript of Clinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Clinuvel Pharmaceuticals Limited on 6ix
Earlier from Clinuvel Pharmaceuticals
- Notification of cessation of securities - CUV
- Application for quotation of securities - CUV
- Change in substantial holding
- Notice of Annual General Meeting/Proxy Form
- New CUV105 vitiligo cases presented to EADV
Later from Clinuvel Pharmaceuticals
All Clinuvel Pharmaceuticals news releasesFollow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.
Follow Clinuvel Pharmaceuticals